XML 25 R14.htm IDEA: XBRL DOCUMENT v3.25.3
STOCK-BASED COMPENSATION EXPENSE
 9 Months Ended
Sep. 30, 2025
Share-Based Payment Arrangement [Abstract]  
STOCK-BASED COMPENSATION EXPENSE

NOTE 8: STOCK-BASED COMPENSATION EXPENSE

 

The Company recorded stock-based compensation for the three and nine months ended September 30, 2025 and 2024, respectively, that were included in the following line items in our condensed consolidated statements of operations (in thousands):

 

             
  

Three months ended

September 30,

  

Nine months ended

September 30,

 
   2025   2024   2025   2024 
                 
Cost of revenue  $23   $38   $76   $114 
Research and development   36    47    128    141 
Selling   18    27    65    81 
General and administrative   133    155    455    465 
                     
Total  $210   $267   $724   $801 

 

Stock-based compensation expense for three months ended September 30, 2025 and 2024 included $50,000 and $50,000, respectively, and for the nine month periods ended September 30, 2025 and 2024 included $150,000 and $153,736, respectively, related to restricted stock awards that directors are entitled to receive pursuant to the Director Compensation Plan. Under this plan each of the five Company’s independent directors is entitled to an Annual Equity Retainer in the amount of $40,000, to be granted on the date of the Company’s annual meeting of shareholders.

 

The following table summarizes stock options activity through September 30, 2025:

 

       Weighted 
   Stock Option   Average 
   Awards   Exercise 
   (in shares)   Price 
         
Outstanding at January 1, 2025   823,125   $8.24 
Forfeited   (15,500)   11.04 
Outstanding at September 30, 2025   807,625    8.19 

 

The following table summarizes information about the outstanding and exercisable options at September 30, 2025 by ranges of exercise prices:

 

    Options Outstanding   Options Exercisable 
        Weighted   Weighted           Weighted     
        Average   Average           Average     
Exercise   Number   Remaining   Exercise   Intrinsic   Number   Exercise   Intrinsic 
Price Range   Outstanding   Contractual   Price   Value   Exercisable   Price   Value 
$4.00-7.00    442,125    6.2   $4.54   $     -    385,125   $4.47   $      - 
$7.01-10.00    20,000    2.6   $8.07   $-    20,000   $8.07   $- 
$10.01-13.00    120,000    1.5   $10.52   $-    120,000   $10.52   $- 
$13.01-16.00    225,500    7.5   $14.11   $-    112,000   $14.11   $- 

 

 

NOTE 8: STOCK-BASED COMPENSATION EXPENSE (continued)

 

As of September 30, 2025, there was $0.9 million of unrecognized compensation costs related to stock options expected to be recognized over a weighted average period of 1.4 years.